黑龙江乌苏里江制药有限公司哈尔滨分公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
125
NMPA:125
Drug Approvals
Fexofenadine Hydrochloride Tablets
- Product Name
- 盐酸非索非那定片
- Approval Number
- 国药准字H20090333
- Approval Date
- May 5, 2024
NMPA
Fexofenadine Hydrochloride Capsules
- Product Name
- 盐酸非索非那定胶囊
- Approval Number
- 国药准字H20080402
- Approval Date
- Oct 21, 2023
NMPA
Levodropropizine Dispersible Tablets
- Product Name
- 左羟丙哌嗪分散片
- Approval Number
- 国药准字H20050758
- Approval Date
- May 23, 2023
NMPA
Dirithromycin Enteric-Coated Tablets
- Product Name
- 地红霉素肠溶片
- Approval Number
- 国药准字H20065176
- Approval Date
- Nov 29, 2021
NMPA
Compound Aminopyrine Phenacetin Tablets
- Product Name
- 去痛片
- Approval Number
- 国药准字H23021412
- Approval Date
- Dec 25, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
Clinical Trials
No trials found
News
No news found